The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?

References

• Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics – 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation117(4), e25–e146 (2008).
   PubMed Web of Science ®Google Scholar
• Toschi V, Gallo R, Lettino M et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation95(3), 594–599 (1997).
   PubMed Web of Science ®Google Scholar
• Hansson GK, Libby P, Schonbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ. Res.91, 281–291 (2002).
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Nature420, 868–874 (2002).
   PubMed Web of Science ®Google Scholar
• Broze GJ Jr, Leykam JE, Schwartz BD, Miletich JP. Purification of human brain tissue factor. J. Biol. Chem.260, 10917–10920 (1985).
   PubMedGoogle Scholar
• Paborsky LR, Tate KM, Harris RJ et al. Purification of recombinant human tissue factor. Biochemistry28, 8072–8077 (1989).
   PubMed Web of Science ®Google Scholar
• Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl Acad. Sci. USA87, 6934–6938 (1990).
   PubMed Web of Science ®Google Scholar
• Paborsky LR, Caras LW, Fisher KL, Gorman CM. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. J. Biol. Chem.266, 21911–21916 (1991).
   PubMed Web of Science ®Google Scholar
• Giesen PL, Rauch U, Bohrmann B et al. Blood-borne tissue factor: another view of thrombosis. Proc. Natl Acad. Sci. USA96(5), 2311–2315 (1999).
   PubMed Web of Science ®Google Scholar
• Østerud B, Bjørklid E. Sources of tissue factor. Semin. Thromb. Hemost.32(1), 11–23 (2006).
   PubMed Web of Science ®Google Scholar
• Rivers RP, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. Br. J. Haematol.30(3), 311–316 (1975).
   PubMed Web of Science ®Google Scholar
• Maugeri N, Brambilla M, Camera M. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J. Thromb. Haemost.4(6), 1323–1330 (2006).
   PubMed Web of Science ®Google Scholar
• Sovershaev MA, Lind KF, Devold H et al. No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils. J. Thromb. Haemost.6(10), 1742–1749 (2008).
   PubMed Web of Science ®Google Scholar
• Egorina EM, Sovershaev MA, Olsen JO, Østerud B. Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. Blood111(3), 1208–1216 (2007).
   PubMedGoogle Scholar
• Bouchard BA, Mann KG, Butenas S. No evidence for tissue factor on platelets. Blood116, 854–855 (2010).
   PubMed Web of Science ®Google Scholar
• Camera M, Brambilla M, Toschi V, Tremoli E. Tissue factor expression on platelets is a dynamic event. Blood116(23), 5076–5077 (2010).
   PubMed Web of Science ®Google Scholar
• Zillmann A, Luther T, Muller I et al. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem. Biophys. Res. Commun.281, 603–609 (2001).
   PubMed Web of Science ®Google Scholar
• Weyrich AS, Lindemann S, Tolley ND et al. Change in protein phenotype without a nucleus: translational control in platelets. Sem. Thromb. Hemost.30, 493–500 (2004).
   Google Scholar
• Schwertz H, Tolley ND, Foulks JM et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets. J. Exp. Med.203, 2433–2440 (2006).
   PubMed Web of Science ®Google Scholar
• Lechner D, Weltermann A. Circulating tissue factor-exposing microparticles. Thromb. Res.122(Suppl. 1), S47–S54 (2008).
   PubMed Web of Science ®Google Scholar
• Chargaff E, West R . The biological significance of the thromboplastic protein of blood. J. Biol. Chem.166, 189–197 (1946).
   PubMed Web of Science ®Google Scholar
• Davizon P, López JA . Microparticles and thrombotic disease. Curr. Opin. Hematol.16(5), 334–341 (2009).
   PubMedGoogle Scholar
• Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat. Med.9, 458 (2003).
   PubMed Web of Science ®Google Scholar
• Reininger AJ, Bernlochner I, Penz SM et al. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J. Am. Coll. Cardiol.55(11), 1147–1158 (2010).
   PubMed Web of Science ®Google Scholar
• Day SM, Reeve JL, Pedersen B et al. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood105, 192–198 (2005).
   PubMed Web of Science ®Google Scholar
• Cimmino G, Golino P, Badimon JJ. Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited? Intern. Emerg.6(1), 29–34 (2011).
   PubMedGoogle Scholar
• Bini A, Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood100(8), 2787–2792 (2002).
   PubMedGoogle Scholar
• Bach RR. Tissue factor encryption. Arterioscler. Thromb. Vasc. Biol.26, 456–461 (2006).
   PubMed Web of Science ®Google Scholar
• Henriksson CE, Klingenberg O, Hellum M, Landsverk KS, Joø GB, Westvik AB. Calcium ionophore-induced de-encryption of tissue factor in monocytes is associated with extensive cell death. Thromb. Res.119(5), 621–630 (2007).
   PubMedGoogle Scholar
• Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, Tedgui A . Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation99(3), 348–353 (1999).
   PubMed Web of Science ®Google Scholar
• Leroyer AS, Isobe H, Lesèche G et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. JACC49, 772–777 (2007).
   Google Scholar
• Berckmans RJ, Nieuwland R, Böing AN, Romijn FP, Hack CE, Sturk A. Cell derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost.85, 639–646 (2001).
   PubMed Web of Science ®Google Scholar
• Tutar E, Ozcan M, Kilickap M et al. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation108(13), 1581–1584 (2003).
   PubMed Web of Science ®Google Scholar
• Biró E, Sturk-Maquelin KN, Vogel GM et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J. Thromb. Haemost.1, 2561–2568 (2003).
   PubMed Web of Science ®Google Scholar
• Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood104, 3190–3197 (2004).
   PubMed Web of Science ®Google Scholar
• Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ. Res.96, 1233–1239 (2005).
   PubMed Web of Science ®Google Scholar
• van den Berg YW, van den Hengel LG, Myers HR et al. Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc. Natl Acad. Sci. USA106(46), 19497–19502 (2009).
   PubMedGoogle Scholar
• van den Berg YW, Versteeg HH. Alternatively spliced tissue factor. A crippled protein in coagulation or a key player in non-haemostatic processes? Hamostaseologie30(3), 144–149 (2010).
   PubMedGoogle Scholar
• Bogdanov VY, Cimmino G, Tardos JG, Tunstead JR, Badimon JJ. Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay. J. Thromb. Haemost.7(5), 894–897 (2009).
   PubMed Web of Science ®Google Scholar
• Cimmino G, Cirillo P, Petrillo G et al. Decreased blood-borne tissue factor activity in patients presenting with acute coronary syndrome: should the old paradigm be revisited? Circulation122, A19396 (2010).
   Google Scholar
• Versteeg HH, Spek CA, Peppelenbosch PM, Richel DJ. Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol. Med.10, 1–6 (2004).
   PubMedGoogle Scholar
• Cirillo P, Calì G, Golino P et al. Tissue factor binding of FVIIa triggers smooth muscle cell proliferation via ERK activation. Circulation109, 2911–2916 (2004).
   PubMedGoogle Scholar
• Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am. J. Pathol.134, 1087–1097 (1989).
   PubMed Web of Science ®Google Scholar
• Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc. Natl Acad. Sci. USA86, 2839–2843 (1989).
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med.352, 1685–1695 (2005).
   PubMed Web of Science ®Google Scholar
• Vanhoutte PM. Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ. J.73, 595–601 (2009).
   PubMed Web of Science ®Google Scholar
• Hutter R, Valdiviezo C, Sauter BV et al. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation109(16), 2001–2008 (2004).
   PubMed Web of Science ®Google Scholar
• Ross R. Cell biology of atherosclerosis. Ann. Rev. Physiol.57, 791–804 (1995).
   PubMed Web of Science ®Google Scholar
• Sato Y, Kataoka H, Asada Y et al. Overexpression of tissue factor pathway inhibitor in aortic smooth muscle cells inhibits cell migration induced by tissue factor/Factor VIIa complex. Thromb. Res.94, 401–406 (1999).
   PubMedGoogle Scholar
• Carmeliet P, Mackman N, Moons L et al. Role of tissue factor in embryonic blood vessel development. Nature383, 73–75 (1996).
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N. Engl. J. Med.340(2), 115–126 (1999).
   PubMed Web of Science ®Google Scholar
• Chu JA. Tissue factor upregulation drives a thrombosis–inflammation circuit in relation to cardiovascular complications. Cell. Biochem. Funct.24, 173–192 (2006).
   PubMedGoogle Scholar
• Coughlin SR, Camerer E. PARticipation in inflammation. J. Clin. Invest.111, 25–27 (2003).
   PubMed Web of Science ®Google Scholar
• Chu AJ. Tissue factor mediates inflammation. Arch. Biochem. Biophys.440, 123–132 (2005).
   PubMed Web of Science ®Google Scholar
• Bierhaus A, Zhang Y, Quehenberger P et al. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-κB. Thromb. Haemost.77, 772– 782 (1997).
   PubMed Web of Science ®Google Scholar
• Pendurthi UR, Williams JT, Rao LV. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin: suppression of activation of transcription factors Egr-1, AP-1, and NF-κB. Arterioscler. Thromb. Vasc. Biol.17, 3406–3413 (1997).
   PubMed Web of Science ®Google Scholar
• Mackman N, Brand K, Edgington TS. Lipopolysaccharidemediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites. J. Exp. Med.174, 1517–1526 (1991).
   PubMed Web of Science ®Google Scholar
• Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties: modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J. Biol. Chem.264, 20705–20713 (1989).
   PubMed Web of Science ®Google Scholar
• Christian M, Marangos P, Mak I et al. Interferon-g modulates prolactin and tissue factor expression in differentiating human endometrial stromal cells. Endocrinology142, 3142–3151 (2001).
   PubMed Web of Science ®Google Scholar
• Brand K, Banka CL, Mackman N, Terkeltaub RA, Fan ST, Curtiss LK. Oxidized LDL enhances lipopolysaccharide induced tissue factor expression in human adherent monocytes. Arterioscler. Thromb.14, 790–797 (1994).
   PubMedGoogle Scholar
• Golino P, Ragni M, Cirillo P et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat. Med.2, 35–40 (1996).
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N. Engl. J. Med.331, 417–424 (1994).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med.374, 1557–1565 (2002).
   Google Scholar
• Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med.342, 836–843 (2000).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med.336, 973–979 (1997).
   PubMed Web of Science ®Google Scholar
• Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European concerted action on thrombosis and disabilities, angina pectoris study group. Lancet349, 462–466 (1997).
   PubMed Web of Science ®Google Scholar
• Cirillo P, Golino P, Calabrò P et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc. Res.68(1), 47–55 (2005).
   PubMedGoogle Scholar
• Wu J, Stevenson MJ, Brown JM et al. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance. Arterioscler. Thromb. Vasc. Biol.28, 698–704 (2008).
   PubMed Web of Science ®Google Scholar
• Leatham EW, Bath PM, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br. Heart J.73(1), 10–13 (1995).
   PubMedGoogle Scholar
• Brambilla M, Camera M, Colnago D et al. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet–leukocyte aggregates. Arterioscler. Thromb. Vasc. Biol.28(5), 947–953 (2008).
   PubMed Web of Science ®Google Scholar
• Steppich BA, Braun SL, Stein A et al. Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction. Thromb. J.7, 11 (2009).
   PubMedGoogle Scholar
• Sambola A, Osende J, Hathcock J et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation107(7), 973–977 (2003).
   PubMed Web of Science ®Google Scholar